19
Tue, Aug
73 New Articles

NKO Advises and Radovanovic Stojanovic & Partners Advise on Sopharma's Full Acquisition of Pharmanova

Serbia
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

NKO Partners has advised Sopharma on its full acquisition of Pharmanova. Radovanovic Stojanovic & Partners advised Pharmanova.

According to NKO Partners, the Bulgarian pharmaceuticals giant Sopharma has successfully acquired the remaining 25% of the shares in Pharmanova, making Sopharma the sole 100% shareholder. 

NKO Partners and Radovanovic Stojanovic & Partners advised on Sopharma's acquisition of a 50% in Pharmanova in 2024 (as reported by CEE Legal Matters on August 28, 2024) as well as on the initial acquisition of a 25% stake in 2023 (as reported by CEE Legal Matters on November 10, 2023).

The NKO team included Partners Djordje Nikolic, Branko Jankovic, and Djuro Otasevic. 

The Radovanovic Stojanovic & Partners team included Partner Sasa Stojanovic and Senior Associates Djordje Vicic and Zivko Kovacevic.

NKO Partners at a Glance

NKO Partners is one of the leading law firms providing full scope of commercial law services in Serbia and Montenegro. NKO Partners was founded in 2008 by lawyers with extensive experience in commercial law in the region, who have led the largest and most complex M&A and privatization transactions since the economic and political transition began in the former Yugoslavia, in 2001.

NKO Partners is dedicated to providing high quality legal services to clients across all business sectors and industries, creating solutions that add value to clients’ businesses. The reputation of the firm has been validated by top rankings in the world’s leading directories of recommended law firms, such as Chambers & Partners and The Legal 500.

The firm is a member of numerous professional organizations and associations locally and worldwide, such as IR Global, LNI and Globaladvocaten.

Firm website.